Sentences with phrase «molecular diagnostic assays»

Within our lab we exploit the unique DNA methylation profiles of brain cells to create molecular diagnostic assays capable of detecting peripheral neurological cell free DNA.

Accomplished and highly motivated research professional with extensive experience in infectious disease (hepatitis C virus (HCV), Respiratory syncytial virus (RSV), dengue viruses, Herpes virus (HSV) and influenza viruses) in vaccine development, assay design, development and validation / verification molecular diagnostic assay (MGB - Pleiades chemistry).

Not exact matches

Qiagen creates sample and assay technologies for use in research, applied testing, and molecular diagnostics and has about 2,600 employees worldwide.

Molecular logic Assays using molecular computers, however, could simplify biomedical diaMolecular logic Assays using molecular computers, however, could simplify biomedical diamolecular computers, however, could simplify biomedical diagnostics.

In 2011, she joined the institution's molecular diagnostics laboratory where she has been developing translational next generation sequencing assays and bioinformatics workflows for the Molecular Tumor Profiling Lab of the Yale Cancemolecular diagnostics laboratory where she has been developing translational next generation sequencing assays and bioinformatics workflows for the Molecular Tumor Profiling Lab of the Yale CanceMolecular Tumor Profiling Lab of the Yale Cancer Center.

So we wanted to elucidate the molecular basis of that resistance in the population and design a field applicable diagnostic assay for its monitoring.»

SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a landmark study in which Danish researchers used the Prosigna ® Breast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 and 2003.

Dr. Shendure's research group in Seattle pioneered exome sequencing and its earliest applications to gene discovery for Mendelian disorders (e.g. Miller and Kabuki syndrome) and autism; cell - free DNA diagnostics for cancer and reproductive medicine; massively parallel reporter assays and saturation genome editing; whole organism lineage tracing; and massively parallel molecular profiling of single cells.

Currently, Vaijayanti leads Strand's translational clinical research team that designs and validates next - generation sequencing and molecular assays for Strand's clinical diagnostics offering in personalized medicine.

Blood Systems Research Institute (BSRI) today announced a collaboration to more precisely and efficiently measure the human immunodeficiency virus (HIV) latent reservoir in clinical samples using the Panther system from Hologic, Inc. — a fully automated molecular diagnostics platform that provides test consolidation, random - access sample loading, and proven assay chemistry.

SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, personalized molecular diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid tumors.

Diagnostic Solutions Laboratory is now offering the first molecular pathogen profile, the GI Microbial Assay Plus (GI - MAP).

Dr. Brady worked with Diagnostic Solutions Laboratory to develop and launch the first DNA / PCR molecular assay for GI pathogens performed on stool using an FDA - approved platform and methodology, the GI Microbial Assay Plus (GI - assay for GI pathogens performed on stool using an FDA - approved platform and methodology, the GI Microbial Assay Plus (GI - Assay Plus (GI - MAP).